Review: taking Sucralfate and Omeprazole together


Summary

Drug interactions are reported among people who take Sucralfate and Omeprazole together. This review analyzes the effectiveness and drug interactions between Sucralfate and Omeprazole. It is created by eHealthMe based on reports of 2,870 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Sucralfate

Sucralfate has active ingredients of sucralfate. It is often used in gastrooesophageal reflux disease. (latest outcomes from Sucralfate 6,323 users)

Omeprazole

Omeprazole has active ingredients of omeprazole. It is often used in gastrooesophageal reflux disease. (latest outcomes from Omeprazole 154,416 users)

On Sep, 17, 2016

2,870 people who take Sucralfate, Omeprazole are studied.


Number of reports submitted per year:

Sucralfate and Omeprazole drug interactions.

Drug effectiveness over time:

Sucralfate:
  • < 1 month: 16.0% - (2 of 12 people)
  • 1 - 6 months: 22.0% - (2 of 9 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 60.0% - (3 of 5 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 50.0% - (1 of 2 people)
Omeprazole:
  • < 1 month: 18.0% - (2 of 11 people)
  • 1 - 6 months: 33.0% - (3 of 9 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (3 of 3 people)
  • 2 - 5 years: 20.0% - (1 of 5 people)
  • 5 - 10 years: 50.0% - (3 of 6 people)
  • 10+ years: 25.0% - (1 of 4 people)
  • not specified: 33.0% - (1 of 3 people)

Drug effectiveness by gender:

Sucralfate:
  • female: 28.0% - (6 of 21 people)
  • male: 37.0% - (6 of 16 people)
Omeprazole:
  • female: 45.0% - (11 of 24 people)
  • male: 22.0% - (4 of 18 people)

Drug effectiveness by age:

Sucralfate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 66.0% - (2 of 3 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 33.0% - (3 of 9 people)
  • 50-59: 12.0% - (1 of 8 people)
  • 60+: 45.0% - (5 of 11 people)
Omeprazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 60.0% - (3 of 5 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 40.0% - (4 of 10 people)
  • 50-59: 37.0% - (3 of 8 people)
  • 60+: 25.0% - (3 of 12 people)

Most common drug interactions over time *:

< 1 month:
  • pneumonia
  • dyspnoea
  • cytolytic hepatitis
  • diarrhoea
  • haemoglobin decreased
  • gastrointestinal haemorrhage
  • atrial fibrillation
  • drug eruption
  • escherichia infection
  • liver disorder
1 - 6 months:
  • atrial fibrillation
  • cholelithiasis
  • deep vein thrombosis
  • diarrhoea
  • dyspnoea
  • fatigue
  • nausea
  • oedema peripheral
  • vomiting
  • abdominal sepsis
6 - 12 months:
  • lupus nephritis
  • systemic lupus erythematosus
  • infection
  • depression
  • headache
  • nausea
  • abdominal pain
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • arthralgia
  • bone disorder
1 - 2 years:
  • abdominal pain
  • nausea
  • anaemia
  • chest pain
  • cholelithiasis
  • constipation
  • deep vein thrombosis
  • depression
  • dyspnoea
  • hypotension
2 - 5 years:
  • startle reflex
  • depression
  • osteoporosis
  • arthritis
  • intervertebral disc degeneration
  • arthropathy
  • back pain
  • calcium deficiency
  • spinal osteoarthritis
  • activities of daily living impaired
5 - 10 years:
  • diarrhea
  • dizziness
  • fall
  • gastrooesophageal reflux disease
  • iron deficiency anaemia
  • subdural haematoma
  • abdominal mass
  • aphagia
  • asthma
  • blood potassium decreased
10+ years:
  • fall
  • osteoporosis
  • arthritis
  • road traffic accident
  • depression
  • osteoarthritis
  • ankle fracture
  • bone disorder
  • foot fracture
  • multiple fractures
not specified:
  • nausea
  • pain
  • fatigue
  • dyspnoea
  • gastrooesophageal reflux disease
  • diarrhoea
  • drug ineffective
  • depression
  • anxiety
  • vomiting

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • dyspnoea
  • fatigue
  • diarrhoea
  • depression
  • gastrooesophageal reflux disease
  • anxiety
  • fall
  • arthralgia
male:
  • nausea
  • pyrexia
  • fatigue
  • pain
  • anaemia
  • drug ineffective
  • anxiety
  • asthenia
  • hypotension
  • pneumonia

Most common drug interactions by age *:

0-1:
  • drug ineffective
  • heart rate increased
2-9:
  • anticholinergic syndrome
  • status epilepticus
  • vomiting
  • headache
  • nausea
  • seizure
  • serotonin syndrome
  • cardiac failure congestive
  • diarrhoea
  • drug ineffective
10-19:
  • abdominal pain upper
  • pain
  • pyrexia
  • vomiting
  • pneumonia
  • drug ineffective
  • nausea
  • infection
  • thrombocytopenia
  • cholecystitis chronic
20-29:
  • nausea
  • abdominal pain
  • vomiting
  • cholecystitis chronic
  • abdominal pain upper
  • pain
  • pyrexia
  • hypokalaemia
  • weight decreased
  • cholelithiasis
30-39:
  • abdominal pain
  • nausea
  • fatigue
  • bronchitis
  • depression
  • pain
  • blood cholesterol increased
  • blood alkaline phosphatase increased
  • arthralgia
  • constipation
40-49:
  • nausea
  • chest pain
  • depression
  • dyspnoea
  • pain
  • vomiting
  • anxiety
  • bone disorder
  • fatigue
  • back pain
50-59:
  • nausea
  • gastrooesophageal reflux disease
  • anxiety
  • pain
  • depression
  • diarrhoea
  • fatigue
  • oedema peripheral
  • drug ineffective
  • headache
60+:
  • pain
  • dyspnoea
  • fall
  • nausea
  • drug ineffective
  • asthenia
  • anaemia
  • fatigue
  • gastrooesophageal reflux disease
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Sucralfate and Omeprazole?

Can you answer these questions?

More questions for: Sucralfate, Omeprazole

You may be interested in these reviews

More reviews for: Sucralfate, Omeprazole

On eHealthMe, Sucralfate (sucralfate) is often used to treat gastrooesophageal reflux disease. Omeprazole (omeprazole) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.